Antibiotic and antiviral therapy in COVID-19 patients: Updates from ESCMID Global 2024
06 Jul 2024
In COVID-19 patients, antibiotic therapy should be reserved only for suspected bacterial superinfections.
However, international data from over 1 million hospitalized COVID-19 patients across 65 countries showed that antibiotics were commonly prescribed empirically despite the low rates of reported bacterial co-infection.1
Resources
Antibiotic and antiviral therapy in COVID-19 patients – Updates from ESCMID Global 2024
Antibiotic and antiviral therapy in COVID-19 patients – Updates from ESCMID Global 2024